rs2275845

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.3557-99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0726 in 1,300,796 control chromosomes in the GnomAD database, including 3,747 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.067 ( 340 hom., cov: 33)
Exomes 𝑓: 0.073 ( 3407 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.509

Publications

2 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 13-110170831-G-A is Benign according to our data. Variant chr13-110170831-G-A is described in ClinVar as Benign. ClinVar VariationId is 1241907.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.107 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.3557-99C>T intron_variant Intron 41 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.3557-99C>T intron_variant Intron 41 of 51 1 NM_001845.6 ENSP00000364979.4

Frequencies

GnomAD3 genomes
AF:
0.0672
AC:
10229
AN:
152184
Hom.:
339
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0483
Gnomad AMI
AF:
0.0450
Gnomad AMR
AF:
0.0815
Gnomad ASJ
AF:
0.0199
Gnomad EAS
AF:
0.114
Gnomad SAS
AF:
0.0610
Gnomad FIN
AF:
0.0923
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0711
Gnomad OTH
AF:
0.0745
GnomAD4 exome
AF:
0.0733
AC:
84153
AN:
1148494
Hom.:
3407
AF XY:
0.0727
AC XY:
42381
AN XY:
582964
show subpopulations
African (AFR)
AF:
0.0468
AC:
1295
AN:
27686
American (AMR)
AF:
0.117
AC:
4684
AN:
40186
Ashkenazi Jewish (ASJ)
AF:
0.0168
AC:
401
AN:
23916
East Asian (EAS)
AF:
0.134
AC:
5046
AN:
37784
South Asian (SAS)
AF:
0.0631
AC:
4923
AN:
77978
European-Finnish (FIN)
AF:
0.0881
AC:
3665
AN:
41616
Middle Eastern (MID)
AF:
0.0190
AC:
97
AN:
5104
European-Non Finnish (NFE)
AF:
0.0720
AC:
60802
AN:
843970
Other (OTH)
AF:
0.0645
AC:
3240
AN:
50254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4281
8562
12844
17125
21406
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2090
4180
6270
8360
10450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0672
AC:
10242
AN:
152302
Hom.:
340
Cov.:
33
AF XY:
0.0694
AC XY:
5165
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0484
AC:
2011
AN:
41562
American (AMR)
AF:
0.0815
AC:
1248
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0199
AC:
69
AN:
3472
East Asian (EAS)
AF:
0.114
AC:
592
AN:
5180
South Asian (SAS)
AF:
0.0609
AC:
294
AN:
4830
European-Finnish (FIN)
AF:
0.0923
AC:
980
AN:
10618
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0711
AC:
4838
AN:
68014
Other (OTH)
AF:
0.0742
AC:
157
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
505
1009
1514
2018
2523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0679
Hom.:
128
Bravo
AF:
0.0675

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.83
DANN
Benign
0.53
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2275845; hg19: chr13-110823178; COSMIC: COSV65430820; API